1,188 filings
Page 14 of 60
8-K
vrol3vq1bpy5v 73t4
13 Nov 17
2017 Third Quarter Financial Results and Business Update Teleconference
12:00am
8-K
qgm2uoum
7 Nov 17
Vivus Reports Third Quarter 2017 Financial Results
12:00am
8-K
7a2jidy0ws8v7aj87n
2 Nov 17
VIVUS Completes Tacrolimus Pre-IND Meeting With FDA
12:00am
4
4ugkm
31 Oct 17
VIVUS / HERM ROSENMAN ownership change
12:00am
4
49jbtya
31 Oct 17
VIVUS / Eric W Roberts ownership change
12:00am
4
utgqi7an0w8i9yhwkb
31 Oct 17
VIVUS / Jorge MD Plutzky ownership change
12:00am
4
0m01 qffue
31 Oct 17
VIVUS / David Y Norton ownership change
12:00am
8-K
i9hxd13fkt 8p71r5
31 Oct 17
Departure of Directors or Certain Officers
12:00am
4
hm6c5s
31 Oct 17
VIVUS / Allan Shaw ownership change
12:00am
4
jp578cy
17 Oct 17
VIVUS / Eric W Roberts ownership change
12:00am
4
b75nvly
17 Oct 17
VIVUS / Allan Shaw ownership change
12:00am
CT ORDER
ctfbch7ntw6 6vcil
12 Oct 17
Confidential treatment order
12:00am
8-K
drmcu0qyt
6 Oct 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
4
zdi8kh
4 Oct 17
VIVUS / Santosh T Varghese ownership change
12:00am
4
d0ysg9au q85
19 Sep 17
VIVUS / Eric W Roberts ownership change
12:00am
4
5gg6ravf3z0ony632iu
19 Sep 17
VIVUS / Allan Shaw ownership change
12:00am
8-K
ktifffbc lb
6 Sep 17
VIVUS Announces Tacrolimus Receives Orphan Drug Designation in the European Union for the Treatment of Pulmonary Arterial Hypertension
12:00am